Industries · Health
Pharmacy and diagnostics: drugstores, drug distribution, labs and imaging
How medicines travel from the maker to the patient and who pays at each step; why wholesalers and pharmacies earn thin margins on huge sales; why a cheap generic can earn a pharmacy more than an expensive brand; how labs and imaging centres live on volume against high fixed costs; and what changed from 2024 to 2026 in the United States, Germany, India and the Gulf. General information, not medical advice.
Key takeaways
- Medicines flow from the maker to a wholesaler to a pharmacy to the patient, but most of the money flows the other way from insurers and governments, often through middlemen.
- A pharmacy's profit is gross profit per prescription times the number of prescriptions, plus the front of the store, minus the cost of pharmacists and the store.
- Pharmacy and diagnostics cases usually ask why a chain's profit is falling, whether to open or close stores or labs, whether to go online, or how to respond to a payment cut.
- Explain the drug value chain (maker, wholesaler, pharmacy, payer) and the diagnostics chain (collection, lab, report)
- Calculate gross profit per prescription for branded and generic medicines, and what a cut in reimbursement does to a pharmacy
- Calculate the breakeven volume and margin of a diagnostics lab, and what a price cut does to it
- Describe the players and the shifts from 2024 to 2026 in the United States, Europe, India, the Middle East and Southeast Asia
- Crack typical pharmacy and diagnostics cases, starting with the real driver: who pays, how much per script or test, and how full the fixed capacity is
Lessons
How pharmacies, drug distributors and diagnostics labs work
The chain from medicine maker to patient, who pays the pharmacy in different countries, how labs and imaging centres run, and the measures each one watches.
Pharmacy and lab economics: scripts, generics, reimbursement and test volume
Why a generic can earn a pharmacy more than a branded medicine, what a reimbursement cut does to a store, and how a lab reaches breakeven.
Pharmacy and diagnostics players, trends 2024 to 2026, and how to crack the cases
Who the players are by region, what changed from 2024 to 2026 (US pharmacy closures, middlemen under scrutiny, online pharmacies, cheaper generics in India, lab payment rules), typical prompts, traps and drills.
Worked cases in this module
Look it up
Key terms